Coronavirus vaccines comparative analysis

Several vaccines have been developed to battle coronavirus in different countries. Let's find out where and which of them are used, who and in what volumes is ready to buy them.
11 COVID-19 vaccines have been developed around the world, but only five of them - the Russian Sputnik V, the German-US Pfizer/BioNTech, the US Moderna, the British AstraZeneca and the Chinese Sinopharm - have passed all necessary tests, are used for vaccination and supplied abroad. Only three of them are more than 90% effective including Sputnik V, whose safety has been confirmed by the results of a phase III clinical trial published in the Lancet journal in early February 2021. As for the number of doses used, the Russian vaccine is still behind Moderna and Pfizer/BioNTech in the USA, Sinopharm and Sinovac in China, and AstraZeneca and Pfizer/BioNTech in the UK. Israel may be the first country to defeat coronavirus through vaccination. Since the beginning of vaccination (December 19), a third of the population - and about 65% of the elderly people - has already been vaccinated there.
The vaccination is running in 88 countries as of February 20, 2021. Sputnik V is registered in 36 countries
Sources: Our World In Data, statistical and health authorities of countries, Russian regional coronavirus headquarters, regional governments and ministries of health, Twitter Sputnik V, Russian Direct Investment Fund. Data as of February 20, .2021
Тop 7 Facts about Russian COVID-19 Vaccines



Sputnik V was the first coronavirus vaccine
It was developed by the the Gamaleya National Research Center for Epidemiology and Microbiology and registered on August 11, 2020
Fact 1

The EpiVacCorona vaccine by the Vector Center was included into the State Register of Drugs under # LP-006504 on October 13, 2020
It became the second officially registered Russian COVID-19 vaccine
Fact 2


Mass vaccination against COVID-19 started in Russia on January 18
Fact 3


About 2.2 million people in Russia received the first component of Sputnik V within the first five week of mass vaccination
US film director Oliver Stone, Israeli TV host Dov Gil-Har, Serbian film director Emir Kusturica, Italian Ambassador to Russia Pasquale Terracciano, and The New York Times' own correspondent in Moscow Andrew Kramer joined them in vaccinating against COVID
Fact 4


Professor Giuseppe Remuzzi, director of the Italian Mario Negri Institute for Pharmacological Research, called Sputnik V a great vaccine
Dean Winslow, an infectious disease specialist at Stanford University Medical Center in California, believes that Sputnik V will play an important role in the world's fight against pandemics. Florian Thalhammer, a leading infectious disease doctor at the Medical University of Vienna, compared the Russian vaccine to the legendary Kalashnikov assault rifle. In his opinion, the vaccine is as reliable and effective as AK-47
Fact 5

One more Russian COVID-19 vaccine, CoviVac, developed by the Chumakov Federal Research and Development Center for Immunobiological Preparations of the Russian Academy of Sciences, was registered on February 20
It became the third vaccine approved for widespread use in our country
Fact 6


Several other companies are developing COVID-19 vaccines in Russia
Biocad is working on three vaccines. One of these vaccines is the company's own development. The second one is being created together with the Vector Center. And the third one is being developed with the Institute of Experimental Medicine in St. Petersburg. Another player in the pharmaceutical market that is working on a SARS-CoV-2 vaccine is Nanolek
Fact 7
E-mail: pressprom@mos.ru
Audience: 16+